These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 115531)

  • 61. Effect of RH-8, flurbiprofen and aspirin on platelet function and coagulation.
    Gupta KC; Manikeri S; Paul T; Tilve GH; Acharya VN; Mehta JM; Sheth UK
    Indian J Med Res; 1979 Jan; 69():181-8. PubMed ID: 429023
    [No Abstract]   [Full Text] [Related]  

  • 62. An evaluation of the effect of flurbiprofen (2-(2-fluoro-4-biphenylyl) propionic acid) on platelet behaviour.
    Sim AK; McCraw AP; Sim MF
    Thromb Res; 1975 Oct; 7(4):655-68. PubMed ID: 1198551
    [No Abstract]   [Full Text] [Related]  

  • 63. Endotoxin shock in the pig: release of prostaglandins and beneficial effects of flurbiprofen.
    Schrauwen E; Vandeplassche G; Laekeman G; Houvenaghel A
    Arch Int Pharmacodyn Ther; 1983 Apr; 262(2):332-4. PubMed ID: 6409020
    [No Abstract]   [Full Text] [Related]  

  • 64. Inhibition of vascular and platelet prostaglandin synthesis by aspirin.
    N Engl J Med; 1983 Sep; 309(11):670-2. PubMed ID: 6350874
    [No Abstract]   [Full Text] [Related]  

  • 65. The differential inhibition of prostaglandin synthesis in platelets and vascular tissue in response to aspirin.
    Shaikh BS; Bott SJ; Demers LM
    Prostaglandins Med; 1980 Jun; 4(6):439-47. PubMed ID: 6774354
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The kinetic factors that determine the affinity and selectivity for slow binding inhibition of human prostaglandin H synthase 1 and 2 by indomethacin and flurbiprofen.
    Callan OH; So OY; Swinney DC
    J Biol Chem; 1996 Feb; 271(7):3548-54. PubMed ID: 8631960
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reduced platelet aggregation in women after intercourse: a possible role for the cyclooxygenase pathway.
    Mayoral-Andrade G; Pérez-Campos-Mayoral L; Majluf-Cruz A; Perez-Campos Mayoral E; Perez Campos Mayoral C; Rocha-Núñez A; Martinez M; Zenteno E; Hernandez-Gonzalez L; López Juan MG; Pérez-Santiago AD; Pérez-Campos E
    Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):847-853. PubMed ID: 28502103
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Indomethacin, salicylates and prostaglandin binding.
    Attallah AA; Lee JB
    Prostaglandins; 1980 Feb; 19(2):311. PubMed ID: 7384542
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Chemiluminescence in washed human platelets during prostaglandin-thromboxane synthesis induced by N-ethylmaleimide and thimerosal.
    Wörner P; Patscheke H
    Thromb Res; 1980 Jul 1-15; 19(1-2):277-82. PubMed ID: 7444855
    [No Abstract]   [Full Text] [Related]  

  • 70. Sulphinpyrazone and indomethacin for inhibition of platelet prostaglandin synthesis.
    Huijgens PC; van den Berg CA; Imandt LM; Langenhuijsen MM
    Thromb Res; 1981 Nov; 24(3):267-70. PubMed ID: 7336383
    [No Abstract]   [Full Text] [Related]  

  • 71. Aspirin as a quantitative acetylating reagent for the fatty acid oxygenase that forms prostaglandins.
    Rome LH; Lands WE; Roth GJ; Majerus PW
    Prostaglandins; 1976 Jan; 11(1):23-30. PubMed ID: 176688
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Potential anticonvulsive properties of endogenous prostaglandins formed in mouse brain.
    Förstermann U; Heldt R; Knappen F; Hertting G
    Brain Res; 1982 May; 240(2):303-10. PubMed ID: 6809223
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Uptake of 5-hydroxytryptamine by rat blood platelets and its inhibition by adenosine 5'-diphosphate.
    Drummond AH; Gordon JL
    Br J Pharmacol; 1976 Apr; 56(4):417-21. PubMed ID: 1260221
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Aspirin selectively inhibits prostaglandin production in human platelets.
    Smith JB; Willis AL
    Nat New Biol; 1971 Jun; 231(25):235-7. PubMed ID: 5284361
    [No Abstract]   [Full Text] [Related]  

  • 75. Role of the eosinophil in the allergic reactions. II. Release of prostaglandins from human eosinophilic leukocytes.
    Hubscher T
    J Immunol; 1975 Apr; 114(4):1389-93. PubMed ID: 46901
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vitro comparison of the efficacy of cyclooxygenase inhibitors on the adult versus neonatal platelet.
    Stuart MJ; Dusse J
    Biol Neonate; 1985; 47(5):265-9. PubMed ID: 4005330
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Arachidonic acid metabolites and the gastro-intestinal toxicity of anti-inflammatory agents.
    Whittle BJ
    Prostaglandins; 1981; 21 Suppl():113-8. PubMed ID: 6795682
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inhibition of experimental nephrocalcinosis with a prostaglandin synthetase inhibitor.
    Buck AC; Davies RL; Leaker B; Moffat DB
    Br J Urol; 1983 Dec; 55(6):603-8. PubMed ID: 6418262
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Platelet aggregation induced by arachidonic acid is accompanied by release of potential inflammatory mediators distinct from PGE2 and PGF2.
    Vargaftig BB; Zirinis P
    Nat New Biol; 1973 Jul; 244(134):114-6. PubMed ID: 4517254
    [No Abstract]   [Full Text] [Related]  

  • 80. White platelet arterial thrombus formation is inhibited by indomethacin in vivo.
    Bourgain RH
    Arch Int Physiol Biochim; 1978 Feb; 86(1):165-8. PubMed ID: 80173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.